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There has been much discussion about why case fatality
rate from COVID-19 in Italy (at 13.3% as of April 20,
2020, versus a global case fatality rate of 6.9%; Worldometer 2020) is considerably larger than in other countries. In this commentary, we propose several potential
explanations underlying these differences.

Demographics and chronic comorbidities
As widely reported, the novel Severe Acute Respiratory
Syndrome CoronaVirus-2 (SARS-CoV-2) appears to be
most harmful to male elderly (Onder et al. 2020) and Italy
has one of the oldest populations globally. In addition,
Italy’s elderly are well-integrated within society. For
instance, Italian elderly usually live with their extended,
multi-generation families, and actively participate in the
life of their communities (Mazzola et al. 2016). While
socially beneficial, this integration may have facilitated the
exposure of this vulnerable population subgroup to infection more than in other high-income countries. Accordingly, the distribution of the demographic profile of
COVID-19 deceased individuals in Italy is skewed, with
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median age of around 81 years (Istituto Superiore di Sanita’ 2020).
COVID-19 appears to be especially harmful to individuals with preexisting chronic conditions or high-risk
behaviors (smoking), some of which are highly prevalent in
the Italian population, especially among the elderly (Onder
et al. 2020). Accordingly, hypertension, type 2 diabetes,
ischemic heart disease, atrial fibrillation, cancer, chronic
kidney disease, stroke and COPD are among the most
common comorbidities consistently associated with
COVID-19-related Italian fatalities (Onder et al. 2020;
Istituto Superiore di Sanita’ 2020).

Definition of COVID-19 related deaths
In the absence of consistent international guidelines, there
may be considerable discrepancies among countries in
distinguishing deaths from other causes while being
infected with COVID-19. To our understanding, Italy
currently labels COVID-19-related deaths as those where
patients tested positive to the virus, independent of the
primary underlying cause of morbidity. Other countries
may be using a less expansive definition of COVID-19related deaths, as those induced directly by the virus, thus
reporting lower case fatality rates.

Effect of COVID-19 on the Italian National
Health System
The coronavirus pandemic severely stressed the local
provision of health care. In particular, intensive care units
(ICUs) of local and regional hospitals in Italy in general,
and especially in the Lombardy region, had to deal with
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thousands of patients with severe acute respiratory syndromes induced by COVID-19. This nearly exhausted the
available provision not only of ICU beds, but also of respirators and ventilators (Rosenbaum 2020). In addition, the
epidemic progressed at a speed that made adding capacity
challenging while the global supply chain is stretched and
at times broken. This suggests that some patients may have
not received the best possible care, leading to worse health
outcomes. These events are remarkable, since Lombardy is
one of the wealthiest regions in Europe, while the Italian
Health System is widely considered among the best in the
world in terms of access, quantity and quality of care
provided (World Population Review 2020).
It is equally important to emphasize that COVID-related
case fatality rates within Italy display significant heterogeneity, e.g., as high as 18.5% in Lombardy, also the most
populous region of Italy, and as low as 4.3% in Umbria,
among the least populated, as of April 20, 2020 (Dipartimento della Protezione Civile 2020). Yet, the regional case
fatality rate is also highly positively correlated (up to 68%)
with the regional-level number of hospitalized symptomatic and/or ICU-admitted COVID-19 patients, once
again suggesting that fatalities spiked as hospitals’ capacity
diminished, especially in the most affected northern
regions where the vast majority of deaths occurred.

Extent of testing for COVID-19 and the tip
of the iceberg
Italy and South Korea are among the countries where the
most tests per thousand people for COVID-19 were performed as of April 20, 2020 (Our World In Data 2020). Of
course, running more tests implies in principle that a larger
portion of the coronavirus iceberg would be observed,
including infected but asymptomatic individuals, relative
to other countries where COVID-19 is stealthily spreading
and killing. However, Italy has so far mostly tested
symptomatic people, while it was widely reported that
South Korea adopted extensive contact tracing by testing
several asymptomatic people for each symptomatic one on
the basis of immediate proximity. Nevertheless, this
approach (adopted by other Asian countries as well) also
raises concerns for the potential violation of privacy and
human rights; hence, its applicability to Western countries
is uncertain.
In light of these observations, we developed a simple
model to estimate the Italian coronavirus under-testing and
iceberg as a function of recent estimates of the asymptomatic proportion of infected individuals (Nishiura et al.
2020). Intuitively, our model is based on expressing basic
epidemiological aggregates as explicit functions of
observable and unobservable parameters from the current
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Italian and South Korean testing experiences as well as on
assuming that Italy would have experienced similar
observable epidemiological outcomes as South Korea if it
had adopted the same testing approach. See Pasquariello
and Stranges (2020) for further details and analysis.
We estimate from this model that if Italy had followed
the more proactive South Korean testing approach, it
should have tested between ten and more than twenty
asymptomatic people for each symptomatic one it did test.
Such more widespread testing would have yielded a
coronavirus iceberg from one-tenth to more than two times
larger than its observed tip. These estimates translate in
non-trivial over-reporting of the current COVID-19 case
fatality rate in Italy, as compared to countries (like South
Korea) adopting proactive and extensive contact tracing. In
particular, our model implies an estimated case fatality rate
of slightly less than 9%, i.e., about one-third lower than the
current one.

Lessons learned from the Italian experience
We conclude that Italy’s COVID-19 case fatality rate is
likely to be inflated by such factors as the iceberg effect of
under-testing. However, we also acknowledge that deaths
in Italy are likely higher than in other equally affected
countries because of its unique demographic and socioeconomic profile. In addition, we emphasize the central role
played by the stress imposed by the pandemic on the health
care system of the most affected areas and its likely contribution to their high death tolls.
Therefore, we caution from ignoring the lessons that the
Italian circumstances may offer to other impacted Western
countries. The COVID-19 pandemic has exposed several
intrinsic structural limitations of the Italian national public
health care system, especially a lack of coordinated and
timely response mechanisms for enabling rapid actions,
like those deployed by several Asian countries, and a lack
of adequate community response, which is critical for
epidemic containment.
In a context of limited evidence and significant uncertainty, Italy is running a massive public health intervention
that is unique in the history of Western democracies. We
all have to hope that it succeeds.
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